1. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors
   Margot A. Lazow et al, 2022, Frontiers in Oncology CrossRef
2. Somatostatin Receptors in Human Meningiomas—Clinicopathological Aspects
   Sofie Tollefsen et al, 2021, Cancers CrossRef
3. The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
   Christina-Katharina Fodi et al, 2022, Journal of Clinical Medicine CrossRef
4. Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues
   Ana Ortolá Buigues et al, 2016, Case Reports in Oncology CrossRef
5. SPECT and PET Imaging of Meningiomas
   Varvara Valotassiou et al, 2012, The Scientific World Journal CrossRef
6. Tumoral Prostate Shows Different Expression Pattern of Somatostatin Receptor 2 (SSTR2) and Phosphotyrosine Phosphatase SHP-1 (PTPN6) According to Tumor Progression
   Ariel Ernesto Cariaga-Martinez et al, 2009, Advances in Urology CrossRef
7. Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
   Wei Wu et al, 2020, Frontiers in Oncology CrossRef
8. Role of Somatostatin Signalling in Neuroendocrine Tumours
   Olesja Rogoza et al, 2022, International Journal of Molecular Sciences CrossRef
9. Germline BAP1 Mutation in a Family With Multi-Generational Meningioma With Rhabdoid Features: A Case Series and Literature Review
   Rahul N. Prasad et al, 2021, Frontiers in Oncology CrossRef